The cellular energy currency that powers every metabolic process in your body. NAD+ levels decline approximately 50% between ages 40–60 — directly contributing to perimenopause fatigue, brain fog, and accelerated aging.
NAD+ is a coenzyme found in every living cell, essential for mitochondrial energy production (oxidative phosphorylation), DNA repair (via PARP enzymes and sirtuins), epigenetic regulation, and cellular signaling. It serves as both an electron carrier in metabolism and a substrate for enzymes that maintain genomic stability. Declining NAD+ impairs all of these processes simultaneously.
NAD+ depletion accelerates during perimenopause, compounding the fatigue, brain fog, and metabolic changes women already experience from hormonal shifts. The framing that resonates: "HRT addresses sex hormone deficiency. NAD+ addresses the parallel energy decline that estrogen replacement alone does not cover." NAD+ supplementation (via IV, injection, or oral precursors like NMN/NR) supports the cellular machinery that keeps everything else running.
IV NAD+ infusions may cause flushing, nausea, cramping, and chest tightness during administration — typically dose-dependent and transient. Subcutaneous injections and oral precursors (NMN, NR) are generally well-tolerated with minimal side effects.
This peptide is part of our Energy & Longevity hub — explore all peptides for this use case.
IV infusions have the highest bioavailability but require clinical visits (45-120 minutes). Subcutaneous injections are effective and convenient for home use. Oral precursors (NMN, NR) are the most accessible option with good evidence for raising NAD+ levels.
NAD+ levels begin declining in the 30s and drop approximately 50% between ages 40-60. Many practitioners recommend starting NAD+ support in the late 30s to early 40s, coinciding with perimenopause onset.
NAD+ supports mitochondrial energy production in brain cells and is involved in neurotransmitter metabolism. While dedicated clinical trials for perimenopause brain fog are lacking, the mechanism is directly relevant to the cellular energy decline that contributes to cognitive symptoms during this transition.
Medical Disclaimer: This profile is for educational purposes only. It is not medical advice, a treatment recommendation, or a prescription guide. Always consult a licensed healthcare provider before starting any peptide therapy. Evidence ratings reflect the current state of published research and may change as new data emerges.
Affiliate Disclosure: Vendor links above are affiliate partnerships. FemPeptides may earn a commission on purchases. This does not influence our editorial content or evidence ratings. Full disclosure →
Take our 60-second quiz for a personalized recommendation based on your goals and life stage.
Find Your Peptide →